A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

Clinical trial NCT07768371 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07768371
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

IgE-Mediated Food Allergy Peanut Allergy Cow Milk Allergy Egg Allergy

Start date: 2026-09-11
Primary completion: 2029-03-30
Enrollment: 576

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.